Protembis raised a €30M Series B round co-led by Segulah Medical Acceleration of Sweden, Italy-based XGEN Venture and Germany-based TechVision Fund.

Germany Sweden Italy 15 March 2024
Share:
Total investments received (USD): 42.37m

Related deals

Top